Cargando…
Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination
We report an interesting case of an indeterminate MTB QuantiFERON for a 26-year-old healthy soldier planned for a routine field exercise to Brunei. Further medical history revealed that the patient had a Moderna mRNA Covid-19 vaccine the day before his MTB QuantiFERON test. The patient was subsequen...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tuberculosis Association of India. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968178/ https://www.ncbi.nlm.nih.gov/pubmed/35760490 http://dx.doi.org/10.1016/j.ijtb.2022.03.019 |
_version_ | 1784678993552736256 |
---|---|
author | Wang, Samuel S.Y. |
author_facet | Wang, Samuel S.Y. |
author_sort | Wang, Samuel S.Y. |
collection | PubMed |
description | We report an interesting case of an indeterminate MTB QuantiFERON for a 26-year-old healthy soldier planned for a routine field exercise to Brunei. Further medical history revealed that the patient had a Moderna mRNA Covid-19 vaccine the day before his MTB QuantiFERON test. The patient was subsequently asked to repeat a T-spot test which was non-reactive, there were no longer any issues with the positive control for the T-spot test. Current Covid-19 research suggests that infection causes a dysregulation of the immune system, perhaps this might also be extrapolated where a Covid-19 vaccine might provoke an immune response which might interfere with some immunological assays. In summary there should be more research invested into the immunological interactions that the newly developed Covid-19 vaccinations have with our existing immunological tests such as QuantiFERON tests which forms a key cornerstone in our fight against tuberculosis. |
format | Online Article Text |
id | pubmed-8968178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Tuberculosis Association of India. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89681782022-03-31 Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination Wang, Samuel S.Y. Indian J Tuberc Letter to the Editor We report an interesting case of an indeterminate MTB QuantiFERON for a 26-year-old healthy soldier planned for a routine field exercise to Brunei. Further medical history revealed that the patient had a Moderna mRNA Covid-19 vaccine the day before his MTB QuantiFERON test. The patient was subsequently asked to repeat a T-spot test which was non-reactive, there were no longer any issues with the positive control for the T-spot test. Current Covid-19 research suggests that infection causes a dysregulation of the immune system, perhaps this might also be extrapolated where a Covid-19 vaccine might provoke an immune response which might interfere with some immunological assays. In summary there should be more research invested into the immunological interactions that the newly developed Covid-19 vaccinations have with our existing immunological tests such as QuantiFERON tests which forms a key cornerstone in our fight against tuberculosis. Tuberculosis Association of India. Published by Elsevier B.V. 2022-07 2022-03-31 /pmc/articles/PMC8968178/ /pubmed/35760490 http://dx.doi.org/10.1016/j.ijtb.2022.03.019 Text en © 2022 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Wang, Samuel S.Y. Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination |
title | Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination |
title_full | Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination |
title_fullStr | Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination |
title_full_unstemmed | Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination |
title_short | Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination |
title_sort | indeterminate mycobacterium tuberculosis quantiferon post moderna mrna covid-19 vaccination |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968178/ https://www.ncbi.nlm.nih.gov/pubmed/35760490 http://dx.doi.org/10.1016/j.ijtb.2022.03.019 |
work_keys_str_mv | AT wangsamuelsy indeterminatemycobacteriumtuberculosisquantiferonpostmodernamrnacovid19vaccination |